Marfrig Global Foods (MBRF3) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
11 Dec, 2025Executive summary
Achieved record consolidated EBITDA of R$ 3.5 billion and net income of R$ 94 million in 3Q25, with highest sales volumes since 2022 and strong execution of value-creation and efficiency strategies.
Expanded market presence, notably in the Middle East, through the launch of Sadia Halal, now the world's largest halal chicken company, and partnerships with HPDC.
Distributed R$ 3.8 billion in dividends and completed the acquisition of Gelprime to boost value-added product share.
Maintained focus on innovation, operational excellence, and sustainability, with significant investments and new export licenses.
Advanced integration and synergy capture post-merger, with mapped synergies and efficiency programs delivering additional value.
Financial highlights
Net revenue reached R$ 41.8 billion, up 9.2% year-over-year; operating cash flow was R$ 3.3 billion.
Adjusted EBITDA totaled R$ 3.5 billion (8.4% margin); net income was R$ 94 million, down from R$ 248 million in 3Q24.
Free cash flow was R$ 555 million after capex and financial expenses.
Leverage ratio at 3.09x EBITDA (LTM); net debt at R$ 41.3 billion, up 10% from Q2.
Distributed R$ 3.8 billion in dividends during the quarter.
Outlook and guidance
Expect to capture R$ 1 billion in synergies from the merger, with R$ 600 million in 2026 and the rest by 2028.
Sadia Halal IPO targeted for 2026/2027 in Riyadh to unlock further value.
Lower interest rates projected to reduce debt service by over R$ 500 million in 2026.
Positive demand outlook for beef and poultry, with balanced global supply and demand expected for 2026.
Continued focus on innovation, operational excellence, and ESG initiatives.
Latest events from Marfrig Global Foods
- Record revenue and volumes in 2025, driven by merger synergies and global expansion.MBRF3
Q4 202527 Mar 2026 - Net revenue and EBITDA surged 16.5% and 64.8%, with leverage and profitability improving.MBRF3
Q2 20242 Feb 2026 - Revenue up 12.4%, EBITDA up 60.4%, leverage down, and major asset sales and dividends approved.MBRF3
Q3 202414 Jan 2026 - Net revenue up 27% to R$38.6B, with leverage at 2.69x and strong South America/BRF results.MBRF3
Q1 202526 Dec 2025 - Record 2024 with robust growth, improved leverage, and strong BRF and South America performance.MBRF3
Q4 202417 Dec 2025 - Net revenue grew 8.6% YoY to R$37.8B, with BRF merger approval and leverage at 2.71x.MBRF3
Q2 202523 Nov 2025